Basics ADC Therapeutics SA IPO Date: May 18, 2020 Sector: Healthcare Industry: Biotech Market Cap: $407.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.79% Avg Daily Range (30 D): $0.12 | 2.79% Avg Daily Range (90 D): $0.10 | 2.74% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): 1.05M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 138 Avg Trade Size (Sh.) (30 D): 120 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 311 Avg Inst. Trade: $1.34M Avg Inst. Trade (30 D): $1.11M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.15M Avg Closing Trade (30 D): $1.11M Avg Closing Trade (90 D): $1.09M Avg Closing Volume: 473.73K     News Jun 26, 2025 @ 3:44 PM The $900 Billion Question: Who Will Deliver the Ne... Source: Prnewswire May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Oct 31, 2024 @ 4:57 PM Cancer Antibody Drug Conjugates Market, Drugs Appr... Source: Researchandmarkets.Com Aug 6, 2024 @ 10:51 PM ADC Therapeutics berichtet über Finanzergebniss... Source: Adc Therapeutics Jul 12, 2024 @ 10:40 AM Antibody Drug Conjugates Market Insights 2018-2023... Source: Researchandmarkets.Com Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.41 $-.3 $-.5 Diluted EPS $-1.41 $-.3 $-.5 Revenue $ 75.21M $ 16.43M $ 18.84M Gross Profit $ $ $ Net Income / Loss $ -166.94M $ -40.97M $ -56.65M Operating Income / Loss $ -136.02M $ -30.97M $ -44.15M Cost of Revenue $ $ $ Net Cash Flow $ -39.53M $ -29.82M $ 69.86M PE Ratio     Splits May 10, 2005:   1:7